Physician

Naomi S. Falk, M.D.

According to 2025 Medicare claims, Naomi Falk, M.D. (NPI: 1649271859) practices ophthalmology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is RETINA CONSULTANT, PLLC (NPI: 1841274016; TIN: 710870207) and primary practice location at 12159-9386. Falk is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), participating under the MSSP model.

Falk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,098 traditional Medicare patients, billed 17,511 HCPCS/CPT codes, and received $1,782,663 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,152 prescription claims across 379 beneficiaries totaling $118,956 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 7 records totaling $7,704. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $114,666 and ending at $118,956. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $1,541,275 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,155,515 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,845,719 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,959,526 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,797,972 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,662,427 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,519,878 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,542,414 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,639,146 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,782,663 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1949,653$1,541,275
20161,41313,585$2,155,515
20171,37311,471$1,845,719
20181,42611,954$1,959,526
20191,40210,417$1,797,972
20201,2279,151$1,662,427
20211,1789,449$1,519,878
20221,11810,548$1,542,414
20231,16215,194$1,639,146
20241,09817,511$1,782,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$98K$196K2015 Drug cost: $114,666 (USD; Tot_Drug_Cst)2016 Drug cost: $196,293 (USD; Tot_Drug_Cst)2017 Drug cost: $175,933 (USD; Tot_Drug_Cst)2018 Drug cost: $145,299 (USD; Tot_Drug_Cst)2019 Drug cost: $136,809 (USD; Tot_Drug_Cst)2020 Drug cost: $137,660 (USD; Tot_Drug_Cst)2021 Drug cost: $135,327 (USD; Tot_Drug_Cst)2022 Drug cost: $118,828 (USD; Tot_Drug_Cst)2023 Drug cost: $151,661 (USD; Tot_Drug_Cst)2024 Drug cost: $118,956 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154251,291$114,666
20164791,478$196,293
20172581,050$175,933
20183071,274$145,299
20192911,191$136,809
20203151,105$137,660
20213471,056$135,327
2022320965$118,828
20233641,074$151,661
20243791,152$118,956

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system9251,481$92
67028Injection of drug into eye2881,178$88
92134Imaging of retina1,0162,251$30
92250Photography of the retina151168$26
92202Extended exam of the back part of the eye with optic nerve drawing169181$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium2527,310$47,628
ProlensaBromfenac Sodium31956$13,124
Prednisolone AcetatePrednisolone Acetate17910,689$11,425
DifluprednateDifluprednate522,144$5,827
IlevroNepafenac12251$4,859

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$105Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$7,599Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Naomi S. Falk, M.D.?

Tedicare shows public-source Medicare data for Naomi S. Falk, M.D. (NPI 1649271859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naomi S. Falk, M.D. have ACO affiliation data?

Naomi S. Falk, M.D. is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612).

What billing organization is linked to Naomi S. Falk, M.D.?

Naomi S. Falk, M.D. is linked to RETINA CONSULTANT, PLLC (billing NPI 1841274016) in the available physician profile data.

Does Naomi S. Falk, M.D. have Open Payments data?

Naomi S. Falk, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.